ARKG vs ARKK
ARK Genomic Revolution ETF vs ARK Innovation ETF
ARKG$30.38
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
ARKK$77.93
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: 0.75%Yield: 0.00%
Side-by-side metrics
| Metric | ARKG | ARKK |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.75% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $1.24B | $6.48B |
YTD return | 7.21% | 3.46% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.35 | 2.36 |
P/E ratio | — | 46.69 |
Last price | $30.38 | $77.93 |
Inception | — | — |
Issuer | ARK | ARK |
ARKG top holdings
Top holdings · ARKG
| TEM | Tempus AI Inc Class A common stock | 9.45% |
| TWST | Twist Bioscience Corp | 9.02% |
| CRSP | CRISPR Therapeutics AG | 8.94% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 5.78% |
| BEAM | Beam Therapeutics Inc | 5.44% |
| ABSI | Absci Corp | 4.79% |
| NTRA | Natera Inc | 4.08% |
| ILMN | Illumina Inc | 4.04% |
| NTLA | Intellia Therapeutics Inc | 3.83% |
| PSNL | Personalis Inc | 3.59% |
Sector breakdown · ARKG
Healthcare100.0%
ARKK top holdings
Top holdings · ARKK
| TSLA | Tesla Inc | 9.73% |
| TEM | Tempus AI Inc Class A common stock | 5.35% |
| AMD | Advanced Micro Devices Inc | 5.18% |
| CRSP | CRISPR Therapeutics AG | 4.98% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.37% |
| ROKU | Roku Inc Class A | 4.33% |
| HOOD | Robinhood Markets Inc Class A | 4.30% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 4.23% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 3.84% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 3.13% |
Sector breakdown · ARKK
Consumer Cyclical13.7%
Technology26.4%
Communication Services10.9%
Financial Services15.4%
Industrials6.3%
Healthcare27.5%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Tempus AI Inc Class A common stock (TEM), which represents 9.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy. Managed by ARK, the fund carries $6.5B in assets under management, an expense ratio of 0.75%. Its largest holding is Tesla Inc (TSLA), which represents 9.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.7%.